Allovir, Inc. Contracts & Agreements
47 Contracts & Agreements
- Business Finance (8 contracts)
- Business Operations (6)
- Human Resources (17)
- Intellectual Property (4)
- Mergers & Acquisitions (1)
- Real Estate (5)
- Uncategorized (6)
- Separation and Release Agreement, dated as of December 19, 2024, by and between AlloVir, Inc. and Diana Brainard (Filed With SEC on December 20, 2024)
- Consulting Agreement, dated as of July 1, 2021, by and between Kalaris Therapeutics, Inc. and Napoleone Ferrara (Filed With SEC on December 9, 2024)
- Separation and Release Agreement, dated as of April 10, 2024 (as revised on April 23, 2024, April 26, 2024 and April 29, 2024), by and between Kalaris Therapeutics. Inc. and... (Filed With SEC on December 9, 2024)
- Business Services Agreement, dated as of July 1, 2023, by and between Kalaris Therapeutics, Inc. (formerly Theia Therapeutics, Inc.) and Samsara BioCapital, LLC (Filed With SEC on December 9, 2024)
- Royalty Agreement, dated as of July 16, 2024, by and between Kalaris Therapeutics, Inc. and Samsara BioCapital L.P (Filed With SEC on December 9, 2024)
- License Agreement, dated as of April 8, 2021, by and between Kalaris Therapeutics, Inc. (formerly Theia Therapeutics, Inc.) and the Regents of the University of California, as... (Filed With SEC on December 9, 2024)
- Kalaris Therapeutics, Inc. 2019 Equity Incentive Plan, as amended, and form of award agreements thereunder (Filed With SEC on December 9, 2024)
- Form of Lock-Up Agreement (Filed With SEC on November 8, 2024)
- Form of Kalaris Support Agreement (Filed With SEC on November 8, 2024)
- Form of AlloVir Support Agreement (Filed With SEC on November 8, 2024)
- Agreement and Plan of Merger, dated as of November 7 2024, by and among AlloVir, Inc., Aurora Merger Sub, Inc. and Kalaris Therapeutics, Inc (Filed With SEC on November 8, 2024)
- Termination Agreement, dated July 1, 2024, by and between AlloVir, Inc. and BP Bay Colony LLC (Filed With SEC on July 2, 2024)
- Sublease Termination Agreement, dated June 5, 2024, by and between AlloVir, Inc. and AMAG Pharmaceuticals, Inc (Filed With SEC on June 11, 2024)
- Amended and Restated Executive Employment Agreement by and between Registrant and Edward Miller, dated as of October 2, 2019 (Filed With SEC on August 3, 2023)
- Underwriting Agreement, dated June 21, 2023, by and among AlloVir, Inc., J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and BoFA Securities, Inc. as representatives of the... (Filed With SEC on June 26, 2023)
- Securities Purchase Agreement, dated as of July 26, 2022, by and between AlloVir, Inc. and the investors identified therein (Filed With SEC on July 27, 2022)
- Senior Executive Cash Bonus Plan (Filed With SEC on February 10, 2022)
- Lease by and between AlloVir, Inc. and BP Bay Colony LLC, dated September 8, 2021 (Filed With SEC on September 13, 2021)
- Sublease by and between AlloVir, Inc. and AMAG Pharmaceuticals, Inc., dated September 8, 2021 (Filed With SEC on September 13, 2021)
- Consulting Agreement by and between AlloVir, Inc. and David Hallal, effective as of July 22, 2021 (Filed With SEC on August 6, 2021)
- Transition Agreement by and between AlloVir, Inc. and David Hallal, dated May 18, 2021 (Filed With SEC on August 6, 2021)
- Consulting Agreement by and between AlloVir, Inc. and David Hallal, effective as of July 22, 2021 (Filed With SEC on July 28, 2021)
- Executive Employment Agreement by and between AlloVir, Inc. and Diana Brainard, effective as of March 17, 2021 (Filed With SEC on March 22, 2021)
- First Amendment to Amended and Restated Exclusive License Agreement by and between Baylor College of Medicine and the Registrant, dated as of November 30, 2020 (Filed With SEC on February 12, 2021)
- Research Collaboration Agreement, by and between Baylor College of Medicine and the Registrant, dated as of November 30, 2020 (Filed With SEC on February 12, 2021)
- Exclusive License Agreement, by and between Baylor College of Medicine and the Registrant, dated as of November 30, 2020 (Filed With SEC on February 12, 2021)
- Executive Employment Agreement, by and between the Registrant and Ercem Atillasoy, dated as of July 14, 2020 (Filed With SEC on February 12, 2021)
- Description of the Registrants securities registered pursuant to Section 12 of the Securities and Exchange Act of 1934, as amended (Filed With SEC on February 12, 2021)
- 2020 Employee Stock Purchase Plan (Filed With SEC on July 23, 2020)
- Form of Underwriting Agreement (Filed With SEC on July 23, 2020)
- Specimen Common Stock Certificate (Filed With SEC on July 23, 2020)
- 2020 Stock Option and Grant Plan, and form of award agreements thereunder (Filed With SEC on July 23, 2020)
- Exclusive License Agreement, by and between Baylor College of Medicine and the Registrant, dated as of June 30, 2017 (Filed With SEC on July 23, 2020)
- Sponsored Research Agreement, by and between Baylor College of Medicine and the Registrant, dated as of June 18, 2019, as amended by the Amendment to Sponsored Research Agreement,... (Filed With SEC on July 23, 2020)
- Redeemable Preferred Stock Redemption Agreement among the Registrant and certain of its stockholders, effective as of September 17, 2018 (Filed With SEC on July 23, 2020)
- Amended and Restated Executive Employment Agreement, by and between the Registrant and David Hallal, dated as of October 2, 2019 (Filed With SEC on July 23, 2020)
- Amended and Restated Executive Employment Agreement, by and between the Registrant and Vikas Sinha, dated as of October 2, 2019 (Filed With SEC on July 23, 2020)
- Executive Employment Agreement, by and between the Registrant and Agustin Melian, dated as of March 21, 2019 (Filed With SEC on July 23, 2020)
- Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, effective as of May 8, 2019 (Filed With SEC on July 6, 2020)
- Consulting Agreement, by and between Ann Leen and the Registrant, dated as of October 1, 2018 (Filed With SEC on July 6, 2020)
- Consulting Agreement, by and between Juan Vera and the Registrant, dated as of October 1, 2018 (Filed With SEC on July 6, 2020)
- Sublease Agreement, by and between ElevateBio Management, Inc. and the Registrant, dated as of May 1, 2019 (Filed With SEC on July 6, 2020)
- Asset Rental Agreement, by and between ElevateBio Management, Inc. and the Registrant, dated as of May 1, 2019 (Filed With SEC on July 6, 2020)
- Lease Agreement between the Registrant and Regus Management Group, LLC, dated as of January 3, 2019, as amended by the Renewal Agreement, entered into on December 10, 2019 (Filed With SEC on July 6, 2020)
- Form of Indemnification Agreement between the Registrant and each of its executive officers (Filed With SEC on July 6, 2020)
- Form of Indemnification Agreement between the Registrant and each of its directors (Filed With SEC on July 6, 2020)
- 2018 Equity Incentive Plan, and form of award agreements thereunder (Filed With SEC on July 6, 2020)
